Advanced Pancreatic Cancer Clinical Trials in Shanghai, Shanghai Municipality
5 recruitingShanghai, Shanghai Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 1
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
Lymph Node MetastasesUnresectable Pancreatic CancerAdvanced Pancreatic Cancer
Chengdu New Radiomedicine Technology Co. LTD.58 enrolled6 locationsNCT06278454
Recruiting
Phase 1Phase 2
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled16 locationsNCT06821503
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Treatment Side EffectsEffects of ImmunotherapyTumor Infiltrating Lymphocyte+2 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098197
Recruiting
Phase 3
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Cancer
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd512 enrolled5 locationsNCT05653453
Recruiting
Phase 2
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd82 enrolled5 locationsNCT06111274